eyes4ears logo.jpg

Hi.

We’re Ben Young and Andrew Pouw, ophthalmology residents who felt that reviewing for clinic, OKAPs, or boards is better when you don’t have to do it alone. Each week we’ll flesh out a new ophthalmology topic with the why and the how.

Episode 18: Anti-VEGF and AMD Trials

Episode 18: Anti-VEGF and AMD Trials

Ben Young and Andrew Pouw
Retina

This week, we review the major flagship anti-VEGF agents, pegaptinib, ranibizumab, bevacizumab, aflibercept, as well as some of the flagship clinical trials, including VISION, MARINA, ANCHOR, CATT, and VIEW 1 and 2.

Also, we are doing a survey to assess the impact of the podcast. If you'd like to support us, take this 4 minute survey: bit.ly/2VpPRND

ANKI Flashcard Decks: Coming, we promise, eventually

Episode 19: Acute Anterior Uveitis I

Episode 19: Acute Anterior Uveitis I
Episode 17: Atypical Optic Neuritis

Episode 17: Atypical Optic Neuritis

Related Posts